Choudhury NJ, Lai WV, Makhnin A, Heller G, et al. A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small cell lung cancer. Clin Cancer Res 2024 Jun 28. doi: 10.1158/1078-0432.CCR-23-3383.
PMID: 38940666